
Fuan Pharmaceutical's Valuation Adjustment Reveals Complex Financial Landscape and Challenges Ahead
2025-10-28 19:09:23Fuan Pharmaceutical (Group) Co., Ltd. has recently experienced a change in its evaluation, reflecting a shift in its valuation metrics. The company shows competitive ratios, including a P/E of 15 and a Price to Book Value of 0.87, but faces challenges with management efficiency and declining sales.
Read MoreNo announcement available
Corporate Actions
No corporate action available






